Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04951518 · ClinicalTrials.gov registry record
VAN Assessment Tool in the Treatment of Acute Ischemic Stroke
A clinical trial, sponsored by Washington Regional Medical Center.
- Completed
- Registry status
- 300
- Enrollment target
NCT04951518: Completed study, sponsored by Washington Regional Medical Center.
NCT04951518 is a clinical trial that has completed, run by Washington Regional Medical Center. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04951518 has completed, sponsored by Washington Regional Medical Center.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
To investigate the reliability of VAN tool as administered by Emergency Medical Services personnel to predict presence of a large vessel occlusion in setting of cerebral ischemic infarction
Primary Outcome
To investigate the reliability of VAN tool as administered by Emergency Medical Services personnel to predict presence of a large vessel occlusion in setting of cerebral ischemic infarction
Interventions
- OTHER VAN Stroke Scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-10-22 |
| Est. Completion | 2022-03-17 |
What the finished NCT04951518 record still lists
NCT04951518 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which VAN Stroke Scale is the first listed.
NCT04951518 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04951518 about?
NCT04951518 is a clinical study titled "VAN Assessment Tool in the Treatment of Acute Ischemic Stroke". To investigate the reliability of VAN tool as administered by Emergency Medical Services personnel to predict presence of a large vessel occlusion in setting of cerebral ischemic infarction
What is the current status of trial NCT04951518?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2020-10-22. Estimated completion is 2022-03-17.
What interventions are being tested in trial NCT04951518?
The interventions under investigation include: VAN Stroke Scale (OTHER).
Who is sponsoring clinical trial NCT04951518?
This trial is sponsored by Washington Regional Medical Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI